SYENSQO SA
Syensqo SA/NV engages in the research, development, and production of advanced materials for industrial and consumer applications worldwide. It operates through Materials, Consumer & Resources segments. The company offers amine ether, amines, fatty amines, and specialty amines; antioxidants and stabilizers; composites; flavors and fragrances, such as vanillin, ethylvanillin, natural vanillin, and… Read more
SYENSQO SA (SHBBF) - Net Assets
Latest net assets as of September 2025: $6.78 Billion USD
Based on the latest financial reports, SYENSQO SA (SHBBF) has net assets worth $6.78 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.24 Billion) and total liabilities ($5.47 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.78 Billion |
| % of Total Assets | 55.35% |
| Annual Growth Rate | 24.86% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 21.76 |
SYENSQO SA - Net Assets Trend (2020–2024)
This chart illustrates how SYENSQO SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SYENSQO SA (2020–2024)
The table below shows the annual net assets of SYENSQO SA from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $7.48 Billion | -1.67% |
| 2023-12-31 | $7.61 Billion | +53.81% |
| 2022-12-31 | $4.95 Billion | +14.20% |
| 2021-12-31 | $4.33 Billion | +40.74% |
| 2020-12-31 | $3.08 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to SYENSQO SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 484800000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $4.85 Billion | 65.23% |
| Other Components | $2.58 Billion | 34.77% |
| Total Equity | $7.43 Billion | 100.00% |
SYENSQO SA Competitors by Market Cap
The table below lists competitors of SYENSQO SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NEXTDC Limited
PINK:NXDCF
|
$5.76 Billion |
|
Shanghai United Imaging Healthcare Co. Ltd. A
SHG:688271
|
$5.76 Billion |
|
Pandora A/S
PINK:PNDZF
|
$5.76 Billion |
|
Ollie's Bargain Outlet Holdings Inc
F:OL6
|
$5.76 Billion |
|
Stericycle Inc
NASDAQ:SRCL
|
$5.75 Billion |
|
St. James’s Place PLC
PINK:STJPF
|
$5.75 Billion |
|
Orica Ltd
AU:ORI
|
$5.75 Billion |
|
Tempus AI, Inc. Class A Common Stock
NASDAQ:TEM
|
$5.74 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SYENSQO SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,567,000,000 to 7,432,000,000, a change of -135,000,000 (-1.8%).
- Net loss of 5,000,000 reduced equity.
- Dividend payments of 170,000,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.00 Million | -0.07% |
| Dividends Paid | $170.00 Million | -2.29% |
| Other Changes | $40.00 Million | +0.54% |
| Total Change | $- | -1.78% |
Book Value vs Market Value Analysis
This analysis compares SYENSQO SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.23x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.05x to 1.23x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $28.95 | $88.17 | x |
| 2021-12-31 | $40.75 | $88.17 | x |
| 2022-12-31 | $46.50 | $88.17 | x |
| 2023-12-31 | $71.92 | $88.17 | x |
| 2024-12-31 | $71.84 | $88.17 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SYENSQO SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.07%
- • Asset Turnover: 0.55x
- • Equity Multiplier: 1.66x
- Recent ROE (-0.07%) is above the historical average (-1.97%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -41.92% | -23.88% | 0.47x | 3.71x | $-1.59 Billion |
| 2021 | 10.29% | 7.36% | 0.48x | 2.94x | $12.60 Million |
| 2022 | 19.30% | 11.70% | 0.60x | 2.77x | $457.70 Million |
| 2023 | 2.55% | 2.73% | 0.55x | 1.70x | $-563.70 Million |
| 2024 | -0.07% | -0.07% | 0.55x | 1.66x | $-748.20 Million |
Industry Comparison
This section compares SYENSQO SA's net assets metrics with peer companies in the Chemicals industry.
Industry Context
- Industry: Chemicals
- Average net assets among peers: $4,551,697,655
- Average return on equity (ROE) among peers: 0.97%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SYENSQO SA (SHBBF) | $6.78 Billion | -41.92% | 0.81x | $5.76 Billion |
| Synalloy Corporation (ACNT) | $26.00 Million | 24.62% | 0.65x | $96.97 Million |
| Advance ZincTek Limited (ADVNF) | $34.99 Million | 6.26% | 0.09x | $5.02 Million |
| AdvanSix Inc (ASIX) | $215.36 Million | 15.86% | 3.20x | $435.20 Million |
| ASP Isotopes Inc. Common Stock (ASPI) | $6.00 Million | -43.48% | 0.19x | $437.78 Million |
| Braskem SA Class A (BAK) | $5.89 Billion | 14.66% | 7.38x | $970.61 Million |
| Bachem Holding AG (BCHMF) | $389.21 Million | 11.99% | 0.14x | $1.98 Billion |
| BASF SE NA O.N. (BFFAF) | $36.11 Billion | 13.04% | 1.40x | $47.09 Billion |
| BioLargo Inc (BLGO) | $-770.20K | 0.00% | 0.00x | $51.87 Million |
| Black Swan Graphene Inc. (BSWGF) | $13.83 Million | -43.99% | 0.01x | $10.07 Million |
| Celanese Corporation (CE) | $2.83 Billion | 10.75% | 2.03x | $6.44 Billion |